ORBIMED ADVISORS LLC – Xenon Pharmaceuticals Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$41.05M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+18.67%
quarter
Xenon Pharmaceuticals Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.44% | -191.9K shares | 623K | $36.1 | 1.13M |
| Q2 2022 | share | Increase | +93.76% | 643.2K shares | 19.46M | $30.42 | 1.32M |
| Q1 2022 | share | Increase | +8.72% | 55K shares | 1.25M | $30.57 | 686K |
| Q4 2021 | share | Increase | +32.29% | 154K shares | 12.42M | $31.99 | 631K |
| Q3 2021 | share | Decrease | -64.25% | -857.21K shares | -17.55M | $15.28 | 477K |
| Q2 2021 | share | Decrease | -46.59% | -1.16M shares | -19.87M | $18.62 | 1.33M |
| Q1 2021 | share | 0.00% | 0 shares | 6.29M | $17.9 | 2.49M | |
| Q4 2020 | share | 0.00% | 0 shares | 10.76M | $15.38 | 2.49M | |
| Q3 2020 | share | 0.00% | 0 shares | -3.67M | $11.07 | 2.49M | |
| Q2 2020 | share | Increase | +50.22% | 835.10K shares | 12.46M | $12.54 | 2.49M |
| Q1 2020 | share | Increase | +161.94% | 1.02M shares | 10.53M | $11.34 | 1.66M |
| Q4 2019 | share | 0.00% | 0 shares | 2.60M | $13.11 | 634.81K | |
| Q3 2019 | share | 0.00% | 0 shares | -539K | $9.01 | 634.81K | |
| Q2 2019 | share | 0.00% | 0 shares | -191K | $9.86 | 634.81K | |
| Q1 2019 | share | 0.00% | 0 shares | 2.44M | $10.16 | 634.81K | |
| Q4 2018 | share | 0.00% | 0 shares | -4.37M | $6.31 | 634.81K | |
| Q3 2018 | share | 0.00% | 0 shares | 2.54M | $13.2 | 634.81K | |
| Q2 2018 | share | 0.00% | 0 shares | 2.72M | $9.2 | 634.81K | |
| Q1 2018 | share | 0.00% | 0 shares | 1.31M | $4.9 | 634.81K | |
| Q4 2017 | share | 0.00% | 0 shares | -80K | $2.83 | 634.81K | |
| Q3 2017 | share | 0.00% | 0 shares | -127K | $2.95 | 634.81K | |
| Q2 2017 | share | 0.00% | 0 shares | -539K | $3.15 | 634.81K | |
| Q1 2017 | share | Decrease | -36.52% | -365.18K shares | -5.16M | $4 | 634.81K |
| Q4 2016 | share | 0.00% | 0 shares | -400K | $7.7 | 1M | |
| Q3 2016 | share | Increase | 0.00% | 1M shares | 8.1M | $8.1 | 1M |